ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00548847
Brief Title: Immunotherapy for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Blast Phase Chronic Myelogenous Leukemia (BP CML), and Myelodysplastic Syndrome (MDS) Relapse After Allogeneic Transplantation

First Submitted : October 22, 2007
First Submitted that Met QC Criteria : October 23, 2007
First Posted : October 24, 2007 (Estimate)

Results First Submitted : July 8, 2016
Results First Submitted that Met QC Criteria : July 8, 2016
Results First Posted : August 18, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : September 18, 2016
Last Update Posted : October 26, 2016 (Estimate)